My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.240 +0.060 (+2.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

22 23 Next >

Iovance Biotherapeutics Shares Are Falling Today: What's Going On? ↗

January 10, 2025

Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4).

Via Benzinga

3 Mid-Cap Stocks That Could Take Off in 2025 ↗

January 09, 2025

Via The Motley Fool

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today ↗

January 02, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 26, 2024

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 20, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Prediction: This Stock Will Beat the Market in 2025 ↗

December 12, 2024

Via The Motley Fool

Peering Into Iovance Biotherapeutics's Recent Short Interest ↗

December 05, 2024

Via Benzinga

Is Iovance Biotherapeutics Stock a Millionaire Maker? ↗

November 27, 2024

Via The Motley Fool

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These ↗

December 19, 2024

These windows of opportunity aren't likely to remain open for much longer.

Via The Motley Fool

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? ↗

December 17, 2024

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

December 07, 2024

Just be ready to ride out some inevitable turbulence along the way.

Via The Motley Fool

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

November 26, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗

November 25, 2024

Via Benzinga

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back ↗

November 23, 2024

Via The Motley Fool

2 Innovative Stocks That Could Deliver Outsize Returns ↗

November 22, 2024

Via The Motley Fool

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More ↗

November 16, 2024

Via The Motley Fool

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

November 07, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

A Peek at Iovance Biotherapeutics's Future Earnings ↗

November 06, 2024

Via Benzinga

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

October 31, 2024

Iovance also to Participate in Upcoming November Conferences

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Is Iovance Biotherapeutics Stock a Buy? ↗

October 04, 2024

The biotech is making important breakthroughs, but is that enough?

Via The Motley Fool

(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest ↗

September 03, 2024

Via Benzinga

Why Iovance Biotherapeutics Stock Triumphed on Thursday ↗

October 24, 2024

With a cutting-edge melanoma drug now on the market, the company is positioned for a breakout.

Via The Motley Fool

3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow ↗

September 26, 2024

This biotech's growth story is going to start moving faster, and soon.

Via The Motley Fool

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today ↗

September 16, 2024

There's plenty of upside with this stock, but it might take a while to realize.

Via The Motley Fool

AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio? ↗

September 08, 2024

The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.

Via Benzinga

Topics Artificial Intelligence

This Is the Biggest Risk With Iovance Biotherapeutics Stock ↗

September 06, 2024

Investors should brace for dilution.

Via The Motley Fool

Iovance Biotherapeutics to Present at Upcoming Conferences

September 03, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Monster Biotech Stocks to Buy Before 2025 ↗

September 02, 2024

These companies are nearly in the sweet spot of risk versus reward in biotech.

Via The Motley Fool

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? ↗

August 27, 2024

This company's new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 16, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.